JP6265371B2 - Cosmetics - Google Patents
Cosmetics Download PDFInfo
- Publication number
- JP6265371B2 JP6265371B2 JP2013174413A JP2013174413A JP6265371B2 JP 6265371 B2 JP6265371 B2 JP 6265371B2 JP 2013174413 A JP2013174413 A JP 2013174413A JP 2013174413 A JP2013174413 A JP 2013174413A JP 6265371 B2 JP6265371 B2 JP 6265371B2
- Authority
- JP
- Japan
- Prior art keywords
- peg
- emulsification
- weight
- oil
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 28
- 239000008346 aqueous phase Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000006096 absorbing agent Substances 0.000 claims description 11
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 10
- 229960000601 octocrylene Drugs 0.000 claims description 10
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 7
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 claims description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229960001679 octinoxate Drugs 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 description 51
- 239000002245 particle Substances 0.000 description 36
- 239000003921 oil Substances 0.000 description 24
- 239000012071 phase Substances 0.000 description 22
- 239000004359 castor oil Substances 0.000 description 21
- 235000019438 castor oil Nutrition 0.000 description 21
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 21
- 230000006750 UV protection Effects 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 15
- 239000006071 cream Substances 0.000 description 15
- 230000000475 sunscreen effect Effects 0.000 description 15
- 239000000516 sunscreening agent Substances 0.000 description 15
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 12
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 10
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 239000013078 crystal Substances 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 8
- KNYAZNABVSEZDS-UHFFFAOYSA-M sodium;2-octadecanoyloxypropanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C([O-])=O KNYAZNABVSEZDS-UHFFFAOYSA-M 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 7
- -1 and accordingly Substances 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 229960000735 docosanol Drugs 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000010696 ester oil Substances 0.000 description 5
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 5
- 229940074052 glyceryl isostearate Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- AOWCOHYBGYRYGE-UHFFFAOYSA-N 1-[2,3-bis(2-oxopropoxy)propoxy]propan-2-one Chemical compound CC(=O)COCC(OCC(C)=O)COCC(C)=O AOWCOHYBGYRYGE-UHFFFAOYSA-N 0.000 description 4
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 4
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229940070765 laurate Drugs 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 3
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 3
- PSQFOYNNWBCJMY-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCO PSQFOYNNWBCJMY-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 3
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229940031726 laureth-10 Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229950004959 sorbitan oleate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- RLKHJWGQKCJXPV-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone;sodium Chemical compound [Na].COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC RLKHJWGQKCJXPV-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- CSEAZGLCWHXBDQ-UHFFFAOYSA-N 1-(3-ethyloctan-3-yloxycarbonyl)naphthalene-2-carboxylic acid Chemical compound C1=CC=C2C(C(=O)OC(CC)(CC)CCCCC)=C(C(O)=O)C=CC2=C1 CSEAZGLCWHXBDQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- UOFCAQWHTQFNHS-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO UOFCAQWHTQFNHS-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- SRCCXKAYSZXZMA-UHFFFAOYSA-N C(CCCCCC)C(C(=O)OC(CO)CO)CCCCCCCCC Chemical compound C(CCCCCC)C(C(=O)OC(CO)CO)CCCCCCCCC SRCCXKAYSZXZMA-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241001507939 Cormus domestica Species 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- XISGXLJXEVXKER-UHFFFAOYSA-N [2,2-bis(hexanoyloxymethyl)-3-hydroxypropyl] hexanoate Chemical compound C(CCCCC)(=O)OCC(COC(CCCCC)=O)(COC(CCCCC)=O)CO XISGXLJXEVXKER-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940084850 beheneth-10 Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229940008394 ceteth-7 Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- YAUPZUPLDOYFST-UHFFFAOYSA-N dodecanoic acid;2-ethyl-2-(hydroxymethyl)propane-1,3-diol Chemical compound CCC(CO)(CO)CO.CCCCCCCCCCCC(O)=O YAUPZUPLDOYFST-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- GTABBGRXERZUAH-UHFFFAOYSA-N hexadecan-1-ol;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCO GTABBGRXERZUAH-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940095127 oleth-20 Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 229940096994 peg-10 glyceryl stearate Drugs 0.000 description 1
- 229940072880 peg-10 stearate Drugs 0.000 description 1
- 229940032076 peg-15 glyceryl stearate Drugs 0.000 description 1
- 229940016593 peg-20 glyceryl isostearate Drugs 0.000 description 1
- 229940102545 peg-20 sorbitan isostearate Drugs 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- NRLLZRJXDKUVHM-UHFFFAOYSA-N tridecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCOC(=O)CCCCCC(C)C NRLLZRJXDKUVHM-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本願発明は構成成分として、1)合成スチブンサイト、2)固形の有機系紫外線吸収剤、3)液状の有機系紫外線吸収剤、4)高級アルコール、5)ペンタステアリン酸ポリグリセリル−10、を適量含有することで、UVAからUVBの広い範囲に渡り紫外線防御能をもちながらも、固形の有機系紫外線吸収剤を結晶析出させることなく安定に含有でき、かつ、みずみずしい使用感を有するO/W乳化型化粧料に関する。 The present invention contains appropriate amounts of 1) synthetic stevensite, 2) solid organic UV absorber, 3) liquid organic UV absorber, 4) higher alcohol, and 5) polyglyceryl-10 pentastearate. O / W emulsification type cosmetics that can contain a solid organic UV absorber stably without crystal precipitation and have a fresh feeling of use while having UV protection ability over a wide range from UVA to UVB. Regarding fees.
地上に降り注ぐ紫外線のうち、UVAと呼ばれる波長領域(320〜400nm)は肌の老化の、UVBと呼ばれる波長領域(280〜320nm)は皮膚ガンなどの原因となっていると言われており、紫外線から肌を守ることは化粧料の重要な機能の一つである。 Among the ultraviolet rays falling on the ground, the wavelength region called UVA (320 to 400 nm) is said to cause skin aging, and the wavelength region called UVB (280 to 320 nm) is said to cause skin cancer. Protecting the skin from skin is one of the important functions of cosmetics.
そのため、従来から紫外線防御効果を化粧料にもたせるために、酸化チタンや酸化亜鉛などの無機系紫外線防御剤やケイ皮酸系等の有機系紫外線吸収剤等が汎用されてきた(非特許文献1〜3)。 For this reason, in order to give cosmetics a UV protection effect, inorganic UV protection agents such as titanium oxide and zinc oxide, organic UV absorbers such as cinnamic acid and the like have been widely used (Non-Patent Document 1). ~ 3).
近年では、美容の観点から一般消費者の紫外線防御への関心が高まり、UVAからUVBの広い紫外線波長領域に渡って高い紫外線防御能を有した化粧料の開発が求められており、特にみずみずしい使用感を有したO/W(水相中に油相が分散した)乳化型化粧料が好まれる傾向にある。 In recent years, consumer interest in UV protection has increased from the viewpoint of beauty, and there has been a demand for the development of cosmetics with high UV protection capabilities over a wide UV wavelength range from UVA to UVB. There is a tendency to prefer emulsified cosmetics having a feeling of O / W (an oil phase dispersed in an aqueous phase).
化粧料に紫外線防御能を付与するための無機系紫外線防御剤としては、酸化亜鉛や微粒子酸化チタンなどが汎用されている。 As an inorganic ultraviolet protective agent for imparting ultraviolet protective ability to cosmetics, zinc oxide, fine particle titanium oxide and the like are widely used.
しかし酸化亜鉛や微粒子酸化チタンを高濃度で含有すると、きしみが生じてしまうため、無機系紫外線防御剤だけでは高い紫外線防御能と良好な使用感を両立させることは難しい。 However, when zinc oxide or fine particle titanium oxide is contained at a high concentration, a squeak is generated. Therefore, it is difficult to achieve both a high UV protection ability and a good feeling of use only with an inorganic UV protection agent.
そのため、化粧料に高い紫外線防御能を付与するには有機系紫外線吸収剤が含有される場合がほとんどである。 Therefore, in most cases, an organic ultraviolet absorber is contained to give cosmetics a high ultraviolet protection ability.
有機系紫外線吸収剤(特にUVA領域に極大吸収波長領域を有するもの)の中には常温において固体のものも多く、それらを乳化系に含有する際には極性の高いエステル油に溶解して含有される。 Many organic ultraviolet absorbers (especially those having a maximum absorption wavelength region in the UVA region) are solid at room temperature, and when they are contained in an emulsifying system, they are dissolved in highly polar ester oils. Is done.
故に、固形の有機系紫外線吸収剤を高濃度で含有するためには溶剤として用いるエステル油も高濃度で含有しなくてはならず、油っぽいべたついた使用感や乳化の不安定化を引き起こしてしまう。 Therefore, in order to contain a solid organic ultraviolet absorber at a high concentration, the ester oil used as a solvent must also be contained at a high concentration, which causes an oily, sticky feel and destabilization of emulsification. End up.
これらの点から、高い紫外線防御能とみずみずしい使用感を両立させることは困難である。 From these points, it is difficult to achieve both high UV protection ability and fresh feeling.
特許文献1では、エステル油の選択により固形の有機系紫外線吸収剤であるジエチルアミノヒドロキシベンゾイル安息香酸ヘキシルを高濃度で含有させているが、それに伴いエステル油も高濃度で含有しなくてはならないため、O/W乳化型化粧料においてもみずみずしさが損なわれてしまう。 In Patent Document 1, a solid organic ultraviolet absorber, diethylaminohydroxybenzoyl hexyl benzoate, is contained at a high concentration by selecting an ester oil, and accordingly, ester oil must also be contained at a high concentration. , Freshness will be impaired even in O / W emulsified cosmetics.
特許文献2では、4−tert−ブチル−4′−メトキシジベンゾイルメタンとヘクトライトと石鹸を含有しているが、石鹸乳化では使用できる界面活性剤も限定されるだけでなく、耐水性にも欠ける。 In Patent Document 2, 4-tert-butyl-4'-methoxydibenzoylmethane, hectorite, and soap are contained, but not only the surfactant that can be used in soap emulsification is limited, but also water resistance. Lack.
以上のように、UVAからUVBまで広い紫外線波長領域に渡って高い紫外線防御能を有しながらも、乳化状態が安定であり、かつみずみずしい使用感の化粧料の開発が求められている。 As described above, there is a demand for the development of cosmetics having a stable emulsification state and a fresh feeling of use while having a high UV protection ability over a wide UV wavelength range from UVA to UVB.
本願発明が解決しようとしている課題は、固形の有機系紫外線吸収剤を安定に含有しつつ、かつみずみずしい使用感の化粧料を提供することである。 The problem to be solved by the invention of the present application is to provide a cosmetic with a fresh feeling of use while stably containing a solid organic ultraviolet absorber.
かかる実情において、本願発明者らは鋭意研究を行った結果、構成成分として、
1)合成スチブンサイト 0.3〜0.5重量%
2)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、4−tert−ブチル−4′−メトキシジベンゾイルメタンから選ばれる1種又は2種の有機系紫外線吸収剤 4〜7重量%
3)メトキシケイ皮酸オクチル、オクトクリレンから選ばれる1種又は2種の有機系紫外線吸収剤 5〜10重量%
4)1種又は2種以上の炭素数16〜22の高級アルコール 0.1〜5重量%
5)ペンタステアリン酸ポリグリセリル−10 0.5〜5重量%
を、含有する水中油型乳化化粧料とすれば、固形の有機系紫外線吸収剤を安定に含有しながら、みずみずしい使用感となることを見出し、本願発明を完成した。
In such a situation, the inventors of the present invention conducted intensive research, and as a component,
1) Synthetic stevensite 0.3-0.5 wt%
2) One to two organic ultraviolet absorbers selected from hexyl diethylaminohydroxybenzoyl benzoate and 4-tert-butyl-4'-methoxydibenzoylmethane 4 to 7% by weight
3) 5 to 10% by weight of one or two organic ultraviolet absorbers selected from octyl methoxycinnamate and octocrylene
4) One or two or more higher alcohols having 16 to 22 carbon atoms 0.1 to 5% by weight
5) 0.5-5% by weight of polyglyceryl-10 pentastearate
And the oil-in-water emulsified cosmetic containing the composition of the present invention has been found to provide a fresh feeling of use while stably containing a solid organic ultraviolet absorber.
本願発明で用いられる合成スチブンサイトは、実質上マグネシウム、ナトリウム、及びケイ素のみで構成される、スチブンサイト型フィロケイ酸マグネシウムナトリウムから成る合成スチブンサイトである。 The synthetic stevensite used in the present invention is a synthetic stevensite composed of a stevensite-type magnesium sodium phyllosilicate substantially composed of only magnesium, sodium, and silicon.
特に好適な合成スチブンサイトとしては、(1)式で表わされる化学組成を有する。 A particularly suitable synthetic stevensite has a chemical composition represented by the formula (1).
(化1)
MgxNaySi4O10(OH)2・Naz (1)
(x+y<3.0、 2.0≦x、y=0 or 0.1、 0<z<1.0)
(Chemical formula 1)
Mg x Na y Si 4 O 10 (OH) 2 .Naz (1)
(X + y <3.0, 2.0 ≦ x, y = 0 or 0.1, 0 <z <1.0)
式中xとyはx+y<3.0という条件下でxは2.0以上の数であり、yは0ないし0.1の数であり、zは0より大で1.0未満の数である。 Where x and y are numbers greater than or equal to 2.0 under the condition x + y <3.0, y is a number from 0 to 0.1, and z is a number greater than 0 and less than 1.0. It is.
安定した乳化状態を維持するために必要な合成スチブンサイトの含有量は、安定性が特に良くpHも適切である0.3〜0.5重量%の範囲である。 The content of the synthetic stevensite necessary for maintaining a stable emulsified state is in the range of 0.3 to 0.5% by weight, which is particularly stable and has a suitable pH.
本願発明では、UVA領域の紫外線防御能を付与するために、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、4−tert−ブチル−4′−メトキシジベンゾイルメタンから選ばれる1種又は2種の固形の有機系紫外線吸収剤を用いる。 In the present invention, one or two solid organic ultraviolet rays selected from hexyl diethylaminohydroxybenzoyl benzoate and 4-tert-butyl-4'-methoxydibenzoylmethane are used to provide UV protection in the UVA region. Use absorbent.
乳化状態を安定に保持できる固形の有機系紫外線吸収剤の含有量は、下記の範囲である。 The content of the solid organic ultraviolet absorber capable of stably maintaining the emulsified state is in the following range.
すなわち、良好な乳化安定性と十分なUVA領域の紫外線防御能を付与するためには4〜7重量%である。 That is, it is 4 to 7% by weight in order to impart good emulsification stability and sufficient UV protection ability in the UVA region .
本願発明においては、より高い紫外線防御能を付与するために、本願発明の効果を損なわない範囲で他の有機系紫外線吸収剤を含有しても構わない。 In this invention, in order to provide higher ultraviolet-ray protective ability, you may contain another organic type ultraviolet absorber in the range which does not impair the effect of this invention.
具体的には、フェニルベンズイミダゾールスルホン酸、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、サリチル酸オクチル、シノキサート、ジヒドロキシジメトキシベンゾフェノン、ジヒドロキシジメトキシベンゾフェノンジスルホン酸ナトリウム、テトラヒドロキシベンゾフェノン、フェルラ酸などが挙げられるが、特にこれらに限定せず、UVAからUVBにかけて広い吸収波長領域を有するビスエチルヘキシルオキシフェノールメトキシフェニルトリアジンが好ましい。 Specific examples include phenylbenzimidazole sulfonic acid, bisethylhexyloxyphenol methoxyphenyl triazine, octyl salicylate, cinoxalate, dihydroxydimethoxybenzophenone, dihydroxydimethoxybenzophenone sodium disulfonate, tetrahydroxybenzophenone, and ferulic acid. Without limitation, bisethylhexyloxyphenol methoxyphenyl triazine having a broad absorption wavelength region from UVA to UVB is preferred.
本願発明では、UVB領域の紫外線防御能を付与するために、メトキシケイ皮酸オクチル、オクトクリレンから選ばれる1種又は2種以上の液状の有機系紫外線吸収剤を用いる。 In this invention, in order to provide the ultraviolet-ray defense capability of a UVB area | region, the 1 type (s) or 2 or more types of liquid organic type ultraviolet absorbers chosen from octyl methoxycinnamate and octocrylene are used.
みずみずしい使用感を付与し、良好な乳化安定性と十分なUVB領域の紫外線防御能を付与するために、液状の有機系紫外線吸収剤の含有量は5〜10重量%である。 Grant fresh feeling, to impart UV protection ability of good emulsifying stability and adequate UVB range, the content of the organic ultraviolet absorber liquid is 5 to 10 wt%.
本願発明では、良好な乳化安定性と使用感を付与するために、炭素数16から22までの高級アルコールを用いる。 In the present invention, a higher alcohol having 16 to 22 carbon atoms is used in order to impart good emulsion stability and usability.
具体的にはセチルアルコール、ステアリルアルコール、イソステアリルアルコール、オレイルアルコール、アラキルアルコール、ベヘニルアルコールなどが挙げられ、これらの混合物を用いても構わない。 Specific examples include cetyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, aralkyl alcohol, and behenyl alcohol, and a mixture thereof may be used.
混合物を具体的に挙げると、アルコール NO.20−B、セタノール、セタノール SP−D50、セタノール SP−D70、セタノール H(以上、高級アルコール工業社製)などが挙げられるが、特にこれらに限定しない。 Specific examples of the mixture include alcohol NO. 20-B, cetanol, cetanol SP-D50, cetanol SP-D70, cetanol H (made by the higher alcohol industry company) etc. are mentioned, However It does not specifically limit.
さらには高級アルコールと多価アルコールがエーテル結合したものも本願発明では高級アルコールとしてみなし、例えばバチルアルコールなどがある。 Further, a compound in which a higher alcohol and a polyhydric alcohol are ether-bonded is regarded as a higher alcohol in the present invention, and examples thereof include batyl alcohol.
良好な乳化安定性と使用感を付与するために必要な高級アルコールの含有量は0.1〜5重量%であり、特に0.5〜3重量%が好ましい。 The content of the higher alcohol necessary for imparting good emulsification stability and usability is 0.1 to 5% by weight, particularly preferably 0.5 to 3% by weight.
本願発明では、HLBが6以下の特定の親油性界面活性剤を使用する。HLBとは界面活性剤の親和性を示す指標であり、HLBが低いもの程油相中に分散しやすいなどの親油性の挙動を示す。 In the present invention, a specific lipophilic surfactant having an HLB of 6 or less is used. HLB is an index indicating the affinity of a surfactant, and the lower the HLB, the more lipophilic behavior such as easier dispersion in the oil phase.
本願発明におけるHLBの算出方法としては、グリフィン法を用いており、以下のように定義される。 As a method for calculating the HLB in the present invention, the Griffin method is used and is defined as follows.
(グリフィン法)
HLB=[親水基の式量/界面活性剤の分子量]×20
(Griffin method)
HLB = [formula weight of hydrophilic group / molecular weight of surfactant] × 20
本願発明で用いられる、特定のHLBが6以下の界面活性剤は、ペンタステアリン酸ポリグリセリル−10である。 Used in the present invention, the specific HLB of 6 or less surfactant is a penta stearic acid poly glyceryl -10.
良好な乳化安定性とみずみずしい使用感を付与するために必要なHLBが6以下の特定の親油性界面活性剤であるペンタステアリン酸ポリグリセリル−10の含有量は0.5〜5重量%であり、特に1〜3重量%が好ましい。 The content of polyglyceryl-10 pentastearate, which is a specific lipophilic surfactant having an HLB of 6 or less necessary for imparting good emulsion stability and a fresh feeling of use, is 0.5 to 5% by weight, 1 to 3 weight% is especially preferable.
さらに本願発明においては、より高い紫外線防御能やカバー力などのメイキャップ効果を付与するために無機系紫外線防御剤やそれらの複合体を含有しても構わない。 Furthermore, in the present invention, an inorganic ultraviolet protective agent or a composite thereof may be contained in order to impart a makeup effect such as higher ultraviolet protective ability or covering power.
具体的にはアナターゼ型酸化チタン、ルチル型酸化チタン、酸化亜鉛、酸化ジルコニウム、黄酸化鉄、赤酸化鉄、黒酸化鉄、酸化チタン複合マイカ、酸化亜鉛複合マイカ、酸化鉄複合マイカなどが挙げられるが、特にこれらに限定せず、また、それらに表面処理を施したものでも構わない。 Specific examples include anatase-type titanium oxide, rutile-type titanium oxide, zinc oxide, zirconium oxide, yellow iron oxide, red iron oxide, black iron oxide, titanium oxide composite mica, zinc oxide composite mica, and iron oxide composite mica. However, it is not particularly limited to these, and those obtained by surface treatment may be used.
また、本願発明においては、固形の有機系紫外線吸収剤をより安定に溶解するため、もしくはなめらかさやしっとり感などの化粧料の使用感を付与するために、本願発明の効果を損なわない範囲でその他のエステル油を含有しても構わない。 Further, in the present invention, in order to dissolve the solid organic ultraviolet absorber more stably, or to give a feeling of use of cosmetics such as smoothness and moist feeling, other within the range not impairing the effect of the present invention. The ester oil may be contained.
具体的には、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12−ヒドロキシステアリン酸コレステリル、ジ2−エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N−アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ2−ヘプチルウンデカン酸グリセリン、トリ2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ2−エチルヘキサン酸ペンタエリスリット、トリ2−エチルヘキサン酸グリセリル、トリイソステアリン酸トリメチロールプロパン、セチル2−エチルヘキサノエート、2−エチルヘキシルパルミテート、イソノナン酸トリデシル、イソノナン酸イソノニル、ナフタリンジカルボン酸ジエチルヘキシル、安息香酸(炭素数12〜15)アルキル、セテアリルイソノナノエート、トリ(カプリル酸・カプリン酸)グリセリン、(ジカプリル酸/カプリン酸)ブチレングリコール、トリミリスチン酸グリセリン、トリ2−ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2−ヘプチルウンデシル、アジピン酸ジイソブチル、N−ラウロイル−L−グルタミン酸−2−オクチルドデシルエステル、アジピン酸ジ2−ヘプチルウンデシル、エチルラウレート、セバチン酸ジ2−エチルヘキシル、ミリスチン酸2−ヘキシルデシル、パルミチン酸−エチルヘキシル、パルミチン酸2−ヘキシルデシル、アジピン酸2−ヘキシルデシル、セバチン酸ジイソプロピル、コハク酸ジ2−エチルヘキシル、酢酸エチル、酢酸ブチル、酢酸アミル、クエン酸トリエチルなどが挙げられるが、特にこれらに限定しない。 Specifically, isopropyl myristate, cetyl octanoate, octyldodecyl myristate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, stearin Isocetyl acid, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, di Glycerin 2-heptylundecanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra-2-ethylene Pentaerythritol trihexanoate, glyceryl tri-2-ethylhexanoate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, tridecyl isononanoate, isononyl isononanoate, diethylhexyl naphthalene dicarboxylate, benzoate Acid (C12-15) alkyl, cetearyl isononanoate, tri (caprylic acid / capric acid) glycerol, (dicaprylic acid / capric acid) butylene glycol, glyceryl trimyristate, tri-2-heptylundecanoic acid glyceride, castor Oil fatty acid methyl ester, oleyl oleate, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octy Dodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, ethylhexyl palmitate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, sebatine Examples include, but are not limited to, diisopropyl acid, di-2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, and triethyl citrate.
本願発明において、乳化安定性を向上させるために、親水性の界面活性剤を含有しても構わない。 In the present invention, a hydrophilic surfactant may be contained in order to improve the emulsion stability.
具体的には、ステアロイル乳酸ナトリウム、ステアリン酸ポリグリセリル−6、ジステアリン酸デカグリセリル−10、オレイン酸PEG−6ソルビタン、PEG−20ソルビットミツロウ、イソステアリン酸ソルビタン、ステアレス−8、ベヘネス−10、ラウレス−10、セテス−6、セテス−7、オレス−7、オレス−8、イソステアリン酸PEG−8グリセリル、コレス−10、トリイソステアリン酸PEG−30グリセリル、トリオレイン酸PEG−30グリセリル、トリイソステアリン酸PEG−30トリメチロールプロパン、ラウリン酸PEG−30水添ヒマシ油、ジラウリン酸PEG−30水添ヒマシ油、オクチルドデセス−10、ジラウリン酸PEG−12、ジイソステアリン酸ポリグリセリル−10、ジイソステアリン酸PEG−20グリセリル、イソステアリン酸PEG−8、イソステアリン酸PEG−10グリセリル、トリイソステアリン酸PEG−60水添ヒマシ油、PEG−20水添ヒマシ油、PPG−4セテス−10、PPG−2−デセス−7、オレス−10、水添ダイマージリノレス−20、ヤシ脂肪酸ソルビタン、イソステアレス−10、ステアレス−11、トリミリスチン酸PEG−40水添ヒマシ油、PCAイソステアリン酸PEG−40水添ヒマシ油、ラウレス−7、イソセテス−10、セテス−10、イソステアリン酸PEG−10、ステアリン酸PEG−10、オレイン酸PEG−10、ステアリン酸PEG−10グリセリル、オレス−12、デシルテトラデセス、コレス−15、ジラウリン酸PEG−16、PEG−30水添ヒマシ油、PEG−30ヒマシ油、トリイソステアリン酸PEG−40水添ヒマシ油、トリオレイン酸PEG−40グリセリル、トリイソステアリン酸PEG−40トリメチロールプロパン、ラウリン酸PEG−40水添ヒマシ油、イソステアリン酸PEG−50水添ヒマシ油、ラウレス−9、PPG−2−デセス−10、セテス−12、イソステアリン酸PEG−12、イソステアリン酸PEG−15グリセリル、オクチルドデセス−16、ジラウリン酸PEG−20、ジイソステアリン酸PEG30−グリセリル、PEG−40水添ヒマシ油、PEG−40ヒマシ油、トリイソステアリン酸PEG−50グリセリル、トリオレイン酸PEG−50グリセリル、トリイソステアリン酸PEG−50トリメチロールプロパン、ラウリン酸PEG−50水添ヒマシ油、ラウレス−10、イソステアレス−15、オレス−15、ステアレス−15、デシルテトラデセス−20、コレス−20、水添ダイマージリノレス−30、PCAイソステアリン酸PEG−60水添ヒマシ油、ステアリン酸PEG−15グリセリル、ベヘネス−20、PPG−2−デセス−12、イソセテス−15、セテス−15、オクチルドデセス−20、コレス−24、PEG−50水添ヒマシ油、PEG−50ヒマシ油、トリイソステアリン酸PEG−60グリセリル、トリオレイン酸PEG−60グリセリル、ラウリン酸PEG−60水添ヒマシ油、ラウレス−12、PPG−2−デセス−15、セテス−17、イソステアレス−20、オレス−20、ステアレス−20、イソステアリン酸PEG−20グリセリル、デシルテトラデセス−25、水添ダイマージリノレス−40、ラウリン酸PEG−12、ラウレス−15、イソセテス−20、セテス−20、イソステアリン酸PEG−20グリセリル、ステアリン酸PEG−20グリセリル、ステアリン酸PEG−20、ポリソルベート80、オレス−23、オクチルドデセス−25、イソステアリン酸PEG−25グリセリル、ベヘネス−30、コレス−30、PEG−60水添ヒマシ油、ヘキサステアリン酸ソルベス−150、PPG−2−デセス−20、イソステアレス−25、ステアレス−25、PCAイソステアリン酸グリセレス−25、ジイソステアリン酸PEG−60グリセリル、セテス−25、ラウレス−20、PEG−20ソルビタンココエート、イソセテス−25、セテス−30、ステアレス−30、ステアリン酸PEG−30、イソステアリン酸PEG−30グリセリル、ステアリン酸PEG−30グリセリル、水添ダイマージリノレス−60、PEG−80水添ヒマシ油、イソステアリン酸PEG−40グリセリル、PEG−100ヒマシ油、トリ(c12−15)パレス−10リン酸、イソステアリン酸PEG−20ソルビタン、ポリソルベート80、ラウリン酸ソルベス−6、PEG−20フィトステロール、ポリソルベート40、イソステアリン酸ポリグリセリル−10などが挙げられるが、特にこれらに限定しない。 Specifically, sodium stearoyl lactate, polyglyceryl-6 stearate, decaglyceryl-10 distearate, PEG-6 sorbitan oleate, PEG-20 sorbitan beeswax, sorbitan isostearate, steareth-8, beheneth-10, laureth-10 , Ceteth-6, ceteth-7, oleth-7, oleth-8, PEG-8 glyceryl isostearate, choles-10, PEG-30 glyceryl triisostearate, PEG-30 glyceryl trioleate, PEG-30 triisostearate Trimethylolpropane, PEG-30 hydrogenated castor oil laurate, PEG-30 hydrogenated castor oil dilaurate, octyldecess-10, PEG-12 dilaurate, polyglyceryl-10 diisostearate, diisostearate PEG-20 glyceryl, PEG-8 isostearate, PEG-10 glyceryl isostearate, PEG-60 hydrogenated castor oil, PEG-20 hydrogenated castor oil, PPG-4 ceteth-10, PPG-2-decession- 7, oleth-10, hydrogenated dimerino linoles-20, palm fatty acid sorbitan, isosteares-10, steareth-11, trimyristate PEG-40 hydrogenated castor oil, PCA isostearic acid PEG-40 hydrogenated castor oil, laureth -7, isocetes-10, ceteth-10, PEG-10 isostearate, PEG-10 stearate, PEG-10 oleate, PEG-10 glyceryl stearate, oleth-12, decyltetradeceth, choles-15, dilaurin Acid PEG-16, PEG-30 hydrogenated castor Oil, PEG-30 castor oil, PEG-40 hydrogenated castor oil triisostearate, PEG-40 glyceryl trioleate, PEG-40 triisostearate trimethylolpropane, PEG-40 hydrogenated castor oil laurate, PEG isostearate -50 hydrogenated castor oil, laureth-9, PPG-2-deceth-10, ceteth-12, PEG-12 isostearate, PEG-15 isostearate, octyldedec-16, PEG-20 dilaurate, PEG30-diisostearate Glyceryl, PEG-40 hydrogenated castor oil, PEG-40 castor oil, PEG-50 glyceryl triisostearate, PEG-50 glyceryl trioleate, PEG-50 triisostearate PEG-50, trimethylolpropane laurate, PEG-5 laurate 0 hydrogenated castor oil, laureth-10, isosteares-15, ores-15, steareth-15, decyltetradeceth-20, choles-20, hydrogenated dimerinolinoles-30, PCA isostearic acid PEG-60 hydrogenated Castor oil, PEG-15 glyceryl stearate, Behenes-20, PPG-2-decess-12, Isoceteth-15, Cetes-15, Octyldecess-20, Colles-24, PEG-50 hydrogenated castor oil, PEG-50 castor Oil, PEG-60 glyceryl triisostearate, PEG-60 glyceryl trioleate, PEG-60 hydrogenated castor oil, laurate-12, PPG-2-deceth-15, ceteth-17, isosteares-20, oleth- 20, steareth-20, PEG-20 glyceryl isostearate Decyltetradeceth-25, hydrogenated dimer dilinoles-40, lauric acid PEG-12, laureth-15, isoceteth-20, ceteth-20, isostearic acid PEG-20 glyceryl, stearic acid PEG-20 glyceryl, stearic acid PEG-20, polysorbate 80, oleth-23, octyldedes-25, PEG-25 glyceryl isostearate, behenez-30, choles-30, PEG-60 hydrogenated castor oil, sorbes hexastearate-150, PPG-2-decess -20, isosteares-25, steareth-25, glyceres-25 PCA isostearate, PEG-60 glyceryl diisostearate, ceteth-25, laureth-20, PEG-20 sorbitan cocoate, isocetes-25, ceteth-30, Tearless-30, PEG-30 stearate, PEG-30 glyceryl isostearate, PEG-30 glyceryl stearate, hydrogenated dimerino linoles-60, PEG-80 hydrogenated castor oil, PEG-40 glyceryl isostearate, PEG- 100 castor oil, tri (c12-15) pares-10 phosphate, PEG-20 sorbitan isostearate, polysorbate 80, sorbes-6 laurate, PEG-20 phytosterol, polysorbate 40, polyglyceryl-10 isostearate and the like. However, it is not particularly limited to these.
また、本願発明の化粧料には、必要に応じて本願発明の効果を損なわない範囲で、通常の化粧料に含有される成分である油脂、ロウ類、炭化水素、脂肪酸、エーテル油、シリコーン油、フッ素油、多価アルコール、糖類、水溶性高分子、保湿剤、防腐剤、pH調整剤、酸化防止剤、金属イオン封鎖剤、染料、香料、可塑剤、有機溶媒、薬剤、動植物抽出物、体質粉体、有機色材、無機色材、パール顔料、表面処理粉体、複合顔料、アミノ酸及びペプチド、ビタミン等を適宜含有することができるが、特にこれらに限定されるものではない。 In addition, the cosmetics of the present invention include fats, waxes, hydrocarbons, fatty acids, ether oils, silicone oils, which are components contained in ordinary cosmetics, as long as the effects of the present invention are not impaired as necessary. , Fluorine oil, polyhydric alcohol, saccharide, water-soluble polymer, moisturizer, preservative, pH adjuster, antioxidant, sequestering agent, dye, fragrance, plasticizer, organic solvent, drug, animal and plant extracts, An extender powder, an organic color material, an inorganic color material, a pearl pigment, a surface-treated powder, a composite pigment, an amino acid and a peptide, a vitamin, and the like can be appropriately contained, but are not particularly limited thereto.
本願発明の化粧料は、難溶性の固形の有機系紫外線吸収剤を安定に含有しつつ、みずみずしい使用感の化粧料を提供でき有用である。 The cosmetic of the present invention is useful because it can provide a freshly used cosmetic while stably containing a hardly soluble solid organic ultraviolet absorber.
次に本願発明の化粧料について実施例を挙げて詳細に説明するが、本願発明はこれらに限定されるものではない。 Next, the cosmetics of the present invention will be described in detail with reference to examples, but the present invention is not limited thereto.
合成スチブンサイトの適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。 In order to determine the appropriate content of synthetic stevensite, a sunscreen cream was prepared with the following formulation.
成分名 含有量(重量%)
(1)ペンタステアリン酸ポリグリセリル−10 1.6
(2)ステアロイル乳酸ナトリウム 0.4
(3)べへニルアルコール 2.0
(4)ステアリルアルコール 0.5
(5)イソノナン酸イソトリデシル 10.0
(6)オクトクリレン 3.0
(7)4−tert−ブチル−4′−メトキシジベンゾイルメタン 5.0
(8)合成スチブンサイト 表1に記載
(9)精製水 残余
(10)1,3−ブチレングリコール 5.0
(11)1,2−ペンタンジオール 1.0
(12)キサンタンガム 0.5
(13)イソステアリン酸ポリグリセリル−10 1.0
Ingredient name Content (wt%)
(1) Polyglyceryl pentastearate-10 1.6
(2) Sodium stearoyl lactate 0.4
(3) Behenyl alcohol 2.0
(4) Stearyl alcohol 0.5
(5) Isotridecyl isononanoate 10.0
(6) Octocrylene 3.0
(7) 4-tert-butyl-4'-methoxydibenzoylmethane 5.0
(8) Synthetic stevensite described in Table 1 (9) Purified water Residual (10) 1,3-butylene glycol 5.0
(11) 1,2-pentanediol 1.0
(12) Xanthan gum 0.5
(13) Polyglyceryl isostearate-10 1.0
成分(1)〜(7)を加熱溶解して油相とし、成分(8)〜(13)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (7) were dissolved by heating to obtain an oil phase, and components (8) to (13) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
成分(8)合成スチブンサイトの含有量を0.01、0.05、0.1、0.3、0.7、1.0、2.0、4.0と変え、乳化安定性とpHを評価した。 The content of component (8) synthetic stevensite was changed to 0.01, 0.05, 0.1, 0.3, 0.7, 1.0, 2.0, 4.0, and the emulsion stability and pH were changed. evaluated.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
pHは、人間の肌が弱酸性であることを考慮し、5〜8の範囲であるものを○、それ以外を×とした。 In consideration of the fact that human skin is weakly acidic, the pH is in the range of 5 to 8, and the others are x.
合成スチブンサイトを0.01重量%含有した比較例1では十分な乳化安定性を付与できなかった。良好な乳化安定性を付与するために必要な合成スチブンサイトの含有量は0.05重量%以上である。また、合成スチブンサイトを4重量%含有した比較例2ではpHが8を超えたため、適切な合成スチブンサイトの含有量は2重量%以下である。 In Comparative Example 1 containing 0.01% by weight of synthetic stevensite, sufficient emulsification stability could not be imparted. The synthetic stevensite content necessary for imparting good emulsion stability is 0.05% by weight or more. Further, in Comparative Example 2 containing 4% by weight of synthetic stevensite, since the pH exceeded 8, the content of appropriate synthetic stevensite is 2% by weight or less.
さらに、乳化安定性が特に良くpHも適度な合成スチブンサイトの濃度範囲としては0.3〜0.5重量%が好ましい。 Further, the concentration range of the synthetic stevensite having particularly good emulsification stability and suitable pH is preferably 0.3 to 0.5% by weight.
次に固形の有機系紫外線吸収剤の適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。 Next, in order to determine an appropriate content of the solid organic ultraviolet absorber, a sunscreen cream was prepared according to the following formulation.
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 1.6
(2)ステアロイル乳酸ナトリウム 0.4
(3)ベヘニルアルコール 2.0
(4)ステアリルアルコール 0.5
(5)イソノナン酸イソトリデシル 10.0
(6)オクトクリレン 5.0
(7)4−tert−ブチル−4′−メトキシジベンゾイルメタン 表2に記載
(8)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 表2に記載
(9)合成スチブンサイト 0.3
(10)精製水 残余
(11)1,3−ブチレングリコール 10.0
(12)1,2−ペンタンジオール 1.0
(13)キサンタンガム 0.5
(14)オレイン酸PEG−6ソルビタン 1.5
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 1.6
(2) Sodium stearoyl lactate 0.4
(3) Behenyl alcohol 2.0
(4) Stearyl alcohol 0.5
(5) Isotridecyl isononanoate 10.0
(6) Octocrylene 5.0
(7) 4-tert-butyl-4'-methoxydibenzoylmethane described in Table 2 (8) hexyl diethylaminohydroxybenzoylbenzoate described in Table 2 (9) synthetic stevensite 0.3
(10) Purified water Residual (11) 1,3-butylene glycol 10.0
(12) 1,2-pentanediol 1.0
(13) Xanthan gum 0.5
(14) PEG-6 sorbitan oleate 1.5
成分(1)〜(8)を加熱溶解して油相とし、成分(9)〜(14)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (8) were dissolved by heating to obtain an oil phase, and components (9) to (14) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
<in vitro UVAPF>
UVA領域の紫外線防御能の評価は、COLIPAのガイドライン(METHOD FOR THE VITRO DETERMINATION OF UVAPROTECTION PROVIDED BY SUNSCREENPRODUCTS,2007)に従い、UVA領域の紫外線防御能の指標であるUVAPFを算出した。
<In vitro UVAPF>
Evaluation of UV protection ability in the UVA region was performed by calculating UVAPF, which is an index of UV protection ability in the UVA region, according to COLIPA guidelines (METHOD FOR THE VITRO DETERMINATION OF UVAPROTECTION PROVIDED BY SUNSCREENPRODUCTTS, 2007).
なお、この評価において化粧料を塗布するアクリル板は、サージカルテープ(3M Blenderm TM Tape 152J−2)で代用した。 In this evaluation, a surgical tape (3M Blender ™ Tape 152J-2) was substituted for the acrylic plate on which the cosmetic material was applied.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
UVAの紫外線防御能は、UVAPFが4以上は◎、2以上4未満は○、1以上2未満は△、1未満は×とした。なお、乳化安定性評価が×のものはUVAPF測定を実施しなかった。 With respect to UVA protective ability of UVA, UVAPF is 4 or more, ◎, 2 or more and less than 4 is ◯, 1 or more and less than 2 is Δ, and less than 1 is ×. In addition, UVAPF measurement was not implemented for the emulsion stability evaluation of x.
以上の結果から、UVA領域に十分な紫外線防御能を付与しつつ、乳化状態を保持するために必要な固形の有機系紫外線吸収剤の含有量は10重量%以下であり、特に高いUVAPFを製剤に付与するためには4〜7重量%が好ましい。 From the above results, the content of the solid organic ultraviolet absorbent necessary for maintaining the emulsified state while providing sufficient UV protection in the UVA region is 10% by weight or less, and a particularly high UVAPF is formulated. 4 to 7% by weight is preferable.
次に液状の有機系紫外線吸収剤の適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。 Next, in order to determine an appropriate content of the liquid organic ultraviolet absorber, a sunscreen cream was prepared according to the following formulation.
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 1.6
(2)ステアロイル乳酸ナトリウム 2.0
(3)べへニルアルコール 2.0
(4)ステアリルアルコール 0.5
(5)イソノナン酸イソトリデシル 10.0
(6)オクトクリレン 表3に記載
(7)メトキシケイ皮酸オクチル 表3に記載
(8)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 6.0
(9)合成スチブンサイト 0.1
(10)精製水 残余
(11)1,3−ブチレングリコール 10.0
(12)1,2−ペンタンジオール 1.0
(13)キサンタンガム 0.5
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 1.6
(2) Sodium stearoyl lactate 2.0
(3) Behenyl alcohol 2.0
(4) Stearyl alcohol 0.5
(5) Isotridecyl isononanoate 10.0
(6) Octocrylene described in Table 3 (7) octyl methoxycinnamate described in Table 3 (8) hexyl diethylaminohydroxybenzoyl benzoate 6.0
(9) Synthetic stevensite 0.1
(10) Purified water Residual (11) 1,3-butylene glycol 10.0
(12) 1,2-pentanediol 1.0
(13) Xanthan gum 0.5
成分(1)〜(8)を加熱溶解して油相とし、成分(9)〜(13)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (8) were dissolved by heating to obtain an oil phase, and components (9) to (13) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
UVB領域の紫外線防御能評価は、下記in vitro SPF測定により見積もった。 The UV protective ability evaluation in the UVB region was estimated by the following in vitro SPF measurement.
使用感は、専門パネラー3人にて評価を行い、乳化安定性評価で×のものは使用感評価を行わなかった。 The feeling of use was evaluated by three professional panelists, and the evaluation of emulsification stability was evaluated for those with x.
<in vitro SPF>
光源は、WACOM社製 XB−25IWI型ソーラーシミュレーターで、透過した紫外線の強度測定は、TOKYO OPTICAL社製 UVR−305/365−D(2)型紫外線強度計を用いて、305nmの透過光を測定した。光源から紫外線強度計までの距離は約30cm、その間にセットする試料は光源から約27cmとし、測定中は、ずれが生じないように十分に固定した。
<In vitro SPF>
The light source is an XB-25IWI solar simulator manufactured by WACOM, and the transmitted UV intensity is measured using a UVR-305 / 365-D (2) UV intensity meter manufactured by TOKYO OPTICAL. did. The distance from the light source to the UV intensity meter was about 30 cm, and the sample set between them was about 27 cm from the light source, and was sufficiently fixed so that no deviation occurred during the measurement.
測定試料は、約5cm四方のスライド用フレームに、3M社製 ブレンダーム サージカルテープを貼付し、測定試料 0.01gを均一に塗布し、調製した。 The measurement sample was prepared by applying a 3M Blender Surgical Tape to a slide frame about 5 cm square and uniformly applying 0.01 g of the measurement sample.
測定は、フレームに貼付したサージカルテープの紫外線透過強度Ibをブランクとし、試料塗布後の紫外線透過強度Iを測定してから、紫外線阻止率{(Ib−I)/Ib}×100(%)を算出した。この算出結果を、既知データをもとに紫外線阻止率とSPFによりプロットした検量線に照らし合わせ、各パウダーファンデーションのSPFをin vitroで見積もった。 For measurement, the ultraviolet transmission intensity Ib of the surgical tape affixed to the frame was used as a blank, the ultraviolet transmission intensity I after the sample application was measured, and then the ultraviolet blocking rate {(Ib-I) / Ib} × 100 (%) was calculated. did. This calculation result was collated with a calibration curve plotted by UV blocking rate and SPF based on known data, and the SPF of each powder foundation was estimated in vitro.
使用感は、専門パネラー3人にて評価を行い、乳化安定性評価で×のものは使用感評価を行わなかった。 The feeling of use was evaluated by three professional panelists, and the evaluation of emulsification stability was evaluated for those with x.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
UVB領域の紫外線防御能は、SPFが20以上が◎、10以上20未満が○、5以上10未満は△、5未満を×とした。 As for the UV protection ability in the UVB region, SPF of 20 or more is ◎, 10 or more and less than 20 is ◯, 5 or more and less than 10 is Δ, and less than 5 is x.
使用感は、3人のパネラーのうち2人以上が化粧料としてなめらかでみずみずしいと感じたものを○、それ以外は×とした。 The feeling of use was evaluated as “good” when two or more of the three panelists felt that the cosmetics were smooth and fresh, and “x” otherwise.
以上の結果から、みずみずしい使用感を付与するためには液状の有機系紫外線吸収剤の含有量は10重量%以下である必要があり、特に良好な乳化安定性と高いSPFを付与するためには5〜10重量%が好ましい。 From the above results, in order to give a fresh feeling to use, the content of the liquid organic ultraviolet absorber needs to be 10% by weight or less, and in order to give particularly good emulsion stability and high SPF. 5 to 10% by weight is preferred.
次に高級アルコールの適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。 Next, in order to determine the appropriate content of higher alcohol, a sunscreen cream was prepared with the following formulation.
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 1.6
(2)ステアロイル乳酸ナトリウム 0.6
(3)べへニルアルコール 表4に記載
(4)セチルアルコール 表4に記載
(5)ミリスチルアルコール 表4に記載
(6)リグノセリルアルコール 表4に記載
(7)イソノナン酸イソトリデシル 10.0
(8)オクトクリレン 5.0
(9)4−tert−ブチル−4′−メトキシジベンゾイルメタン 6.0
(10)合成スチブンサイト 0.2
(11)精製水 残余
(12)1,3−ブチレングリコール 10.0
(13)1,2−ペンタンジオール 1.0
(14)キサンタンガム 0.3
(15)イソステアリン酸ポリグリセリル−10 1.0
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 1.6
(2) Sodium stearoyl lactate 0.6
(3) Behenyl alcohol described in Table 4 (4) cetyl alcohol described in Table 4 (5) myristyl alcohol described in Table 4 (6) lignoceryl alcohol described in Table 4 (7) isotridecyl isononanoate 10.0
(8) Octocrylene 5.0
(9) 4-tert-butyl-4'-methoxydibenzoylmethane 6.0
(10) Synthetic stevensite 0.2
(11) Purified water Residue (12) 1,3-butylene glycol 10.0
(13) 1,2-pentanediol 1.0
(14) Xanthan gum 0.3
(15) Polyglyceryl isostearate-10 1.0
成分(1)〜(9)を加熱溶解して油相とし、成分(10)〜(15)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (9) were dissolved by heating to obtain an oil phase, and components (10) to (15) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
使用感は、専門パネラー3人にて評価を行い、乳化安定性評価で×のものは使用感評価を行わなかった。 The feeling of use was evaluated by three professional panelists, and the evaluation of emulsification stability was evaluated for those with x.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
使用感は、3人のパネラーのうち2人以上が化粧料としてなめらかでみずみずしいと感じたものを○、それ以外は×とした。 The feeling of use was evaluated as “good” when two or more of the three panelists felt that the cosmetics were smooth and fresh, and “x” otherwise.
以上の結果から、良好な乳化安定性と使用感を付与するためには、炭素数16〜22の高級アルコールの含有量を0.1〜5重量%とする必要があり、特に0.5〜3重量%が好ましい。 From the above results, in order to give good emulsification stability and usability, the content of higher alcohol having 16 to 22 carbon atoms needs to be 0.1 to 5% by weight, particularly 0.5 to 3% by weight is preferred.
次に親油性の界面活性剤の適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。 A sunscreen cream was then prepared with the following formulation in order to determine the appropriate content of lipophilic surfactant.
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 表5に記載
(2)ステアロイル乳酸ナトリウム 1.0
(3)べへニルアルコール 2.0
(4)ステアリルアルコール 0.5
(5)イソノナン酸イソトリデシル 10.0
(6)オクトクリレン 5.0
(7)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 5.0
(8)合成スチブンサイト 0.3
(9)精製水 残余
(10)1,3−ブチレングリコール 10.0
(11)1,2−ペンタンジオール 1.0
(12)キサンタンガム 0.5
(13)イソステアリン酸ポリグリセリル−10 1.0
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 described in Table 5 (2) Sodium stearoyl lactate 1.0
(3) Behenyl alcohol 2.0
(4) Stearyl alcohol 0.5
(5) Isotridecyl isononanoate 10.0
(6) Octocrylene 5.0
(7) Diethylaminohydroxybenzoyl hexyl benzoate 5.0
(8) Synthetic stevensite 0.3
(9) Purified water Residual (10) 1,3-butylene glycol 10.0
(11) 1,2-pentanediol 1.0
(12) Xanthan gum 0.5
(13) Polyglyceryl isostearate-10 1.0
成分(1)〜(7)を加熱溶解して油相とし、成分(8)〜(13)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (7) were dissolved by heating to obtain an oil phase, and components (8) to (13) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
使用感は、専門パネラー3人にて評価を行い、乳化安定性評価で×のものは使用感評価を行わなかった。 The feeling of use was evaluated by three professional panelists, and the evaluation of emulsification stability was evaluated for those with x.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
使用感は、3人のパネラーのうち2人以上が化粧料としてなめらかでみずみずしいと感じたものを○、それ以外は×とした。 The feeling of use was evaluated as “good” when two or more of the three panelists felt that the cosmetics were smooth and fresh, and “x” otherwise.
以上の結果から、乳化安定性も使用感も良好となるために必要なHLB6以下の親油性界面活性剤の含有量は0.5〜5重量%であり、特に1〜3重量%が好ましい。 From the above results, the content of the lipophilic surfactant of HLB 6 or less necessary for improving the emulsion stability and usability is 0.5 to 5% by weight, and particularly preferably 1 to 3% by weight.
次に水相の適切な含有量を決定するために、以下の処方でサンスクリーンクリームを調製した。
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 1.5
(2)ステアロイル乳酸ナトリウム 1.5
(3)べへニルアルコール 2.0
(4)ステアリルアルコール 1.0
(5)イソノナン酸イソトリデシル 表6に記載
(6)オクトクリレン 10.0
(7)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 4.0
(8)合成スチブンサイト 0.3
(9)精製水 残余
(10)1,3−ブチレングリコール 10.0
(11)1,2−ペンタンジオール 1.0
(12)キサンタンガム 0.5
A sunscreen cream was then prepared with the following formulation to determine the appropriate content of the aqueous phase.
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 1.5
(2) Sodium stearoyl lactate 1.5
(3) Behenyl alcohol 2.0
(4) Stearyl alcohol 1.0
(5) Isotridecyl isononanoate listed in Table 6 (6) Octocrylene 10.0
(7) Diethylaminohydroxybenzoyl hexyl benzoate 4.0
(8) Synthetic stevensite 0.3
(9) Purified water Residual (10) 1,3-butylene glycol 10.0
(11) 1,2-pentanediol 1.0
(12) Xanthan gum 0.5
成分(1)〜(7)を加熱溶解して油相とし、成分(8)〜(12)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (7) were dissolved by heating to obtain an oil phase, and components (8) to (12) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
<評価方法>
乳化安定性は、本乳化直後と1ヵ月後に目視、及び顕微鏡観察を行い、評価した。
<Evaluation method>
Emulsification stability was evaluated by visual observation and microscopic observation immediately after the main emulsification and one month later.
<判定>
乳化安定性は、顕微鏡観察において、本乳化直後と1ヶ月後を比較して乳化粒子にほとんど差異が認められないものは◎、乳化粒子の粒径にわずかに変化が見られるものは○、乳化粒子の粒径が明らかに倍以上になっているが乳化状態を保っているものを△、結晶析出・乳化粒子の崩壊・目視において油相の染み出しが生じているものは×とした。
<Judgment>
As for the emulsion stability, in the microscopic observation, when there is almost no difference in the emulsified particles compared with immediately after the main emulsification and after one month, ◎, and when the particle size of the emulsified particles is slightly changed, ○, emulsification The particle size of the particles was clearly doubled or more but the emulsified state was maintained, and the case where the crystal precipitation, the emulsification of the emulsified particles, and the oil phase oozed out visually was marked as x.
以上の結果から、良好な乳化安定性を付与するためには、水相の含有量を60〜80重量%とすることが好ましい。 From the above results, in order to give good emulsification stability, the content of the aqueous phase is preferably 60 to 80% by weight.
次にエーテル結合を有した高級アルコール(バチルアルコール)を用いた例として、以下の処方でサンスクリーンクリームを調製した。
成分名 含有量(重量%)
(1)ステアリン酸ポリグリセリル−10 1.5
(2)ステアロイル乳酸ナトリウム 1.0
(3)バチルアルコール 1.0
(4)イソノナン酸イソトリデシル 10.0
(5)オクトクリレン 5.0
(6)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 5.0
(7)合成スチブンサイト 0.3
(8)精製水 残余
(9)1,3−ブチレングリコール 10.0
(10)1,2−ペンタンジオール 1.0
(11)キサンタンガム 0.5
(12)イソステアリン酸ポリグリセリル−10 1.0
Next, as an example using a higher alcohol having an ether bond (batyl alcohol), a sunscreen cream was prepared according to the following formulation.
Ingredient name Content (wt%)
(1) Polyglyceryl stearate-10 1.5
(2) Sodium stearoyl lactate 1.0
(3) Batyl alcohol 1.0
(4) Isotridecyl isononanoate 10.0
(5) Octocrylene 5.0
(6) Diethylaminohydroxybenzoyl hexyl benzoate 5.0
(7) Synthetic stevensite 0.3
(8) Purified water residue (9) 1,3-butylene glycol 10.0
(10) 1,2-pentanediol 1.0
(11) Xanthan gum 0.5
(12) Polyglyceryl isostearate-10 1.0
成分(1)〜(6)を加熱溶解して油相とし、成分(7)〜(12)を混合分散して水相とした。80℃まで加熱した油相と85℃に加熱した水相を混合し、ホモジナイザーを用いて本乳化を行った。乳化後、ホモジナイザーを停止し、ゆるやかに撹拌を行いながら35℃まで冷却し、各サンスクリーンクリームを得た。 Components (1) to (6) were dissolved by heating to obtain an oil phase, and components (7) to (12) were mixed and dispersed to obtain an aqueous phase. The oil phase heated to 80 ° C. and the aqueous phase heated to 85 ° C. were mixed and emulsified using a homogenizer. After emulsification, the homogenizer was stopped and cooled to 35 ° C. while gently stirring to obtain each sunscreen cream.
得られたサンスクリーンクリームは、UVAからUVBに渡る広い波長領域に高い紫外線防御能をもち、結晶析出が起こらず、かつみずみずしい使用感を有した化粧料であった。 The obtained sunscreen cream was a cosmetic having a high UV protection ability over a wide wavelength range from UVA to UVB, no crystal precipitation, and a fresh feeling of use.
本願発明の化粧料で用いた技術は、難溶性の固形の有機系紫外線吸収剤を安定に含有しつつ、みずみずしい使用感を提供する技術である。これは、有機系紫外線吸収剤に限らず、難溶性の薬剤、特に芳香族系の分子骨格を有する薬剤を溶剤で溶かし、その結晶が析出することなく安定に製剤に含有する技術であり他分野への発展性がある。
The technique used in the cosmetic of the present invention is a technique that provides a fresh feeling of use while stably containing a hardly soluble solid organic ultraviolet absorber. This is not limited to organic UV absorbers, it is a technology that dissolves poorly soluble drugs, in particular drugs having an aromatic molecular skeleton, with a solvent and stably contains them in the formulation without precipitation of crystals. There is a potential for development.
Claims (4)
1)合成スチブンサイト 0.3〜0.5重量%
2)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、4−tert−ブチル−4′−メトキシジベンゾイルメタンから選ばれる1種又は2種の有機系紫外線吸収剤 4〜7重量%
3)メトキシケイ皮酸オクチル、オクトクリレンから選ばれる1種又は2種の有機系紫外線吸収剤 5〜10重量%
4)1種又は2種以上の炭素数16〜22の高級アルコール 0.1〜5重量%
5)ペンタステアリン酸ポリグリセリル−10 0.5〜5重量%
を含有する水中油型乳化化粧料。 As a component,
1) Synthetic stevensite 0.3-0.5 wt%
2) One to two organic ultraviolet absorbers selected from hexyl diethylaminohydroxybenzoyl benzoate and 4-tert-butyl-4'-methoxydibenzoylmethane 4 to 7% by weight
3) 5 to 10% by weight of one or two organic ultraviolet absorbers selected from octyl methoxycinnamate and octocrylene
4) One or two or more higher alcohols having 16 to 22 carbon atoms 0.1 to 5% by weight
5) 0.5-5% by weight of polyglyceryl-10 pentastearate
Oil-in-water emulsified cosmetic containing
The oil-in-water emulsified cosmetic according to any one of claims 1 to 3 , wherein the content of the aqueous phase is 60 to 80% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013174413A JP6265371B2 (en) | 2013-08-26 | 2013-08-26 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013174413A JP6265371B2 (en) | 2013-08-26 | 2013-08-26 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015042620A JP2015042620A (en) | 2015-03-05 |
JP6265371B2 true JP6265371B2 (en) | 2018-01-24 |
Family
ID=52696344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013174413A Active JP6265371B2 (en) | 2013-08-26 | 2013-08-26 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6265371B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6478186B2 (en) * | 2015-03-31 | 2019-03-06 | ポーラ化成工業株式会社 | Sunscreen cosmetics and method for producing the same |
JP6630506B2 (en) * | 2015-07-16 | 2020-01-15 | 花王株式会社 | Method for producing oil-in-water emulsion composition |
JP6654686B2 (en) * | 2018-12-14 | 2020-02-26 | ポーラ化成工業株式会社 | Sunscreen cosmetics and method for producing the same |
CN117159398B (en) * | 2023-09-14 | 2024-05-31 | 广州嘉瑞新材料有限公司 | Super-fluid compound sun-screening agent and oil-in-water-in-oil triple sun-screening emulsion |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006151851A (en) * | 2004-11-26 | 2006-06-15 | Shiseido Co Ltd | Emulsion composition |
JP5058351B2 (en) * | 2010-04-13 | 2012-10-24 | 株式会社 資生堂 | Oil-in-water emulsion composition |
-
2013
- 2013-08-26 JP JP2013174413A patent/JP6265371B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015042620A (en) | 2015-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5352116B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
WO2014185317A1 (en) | Oil-in-water cosmetic | |
JP4284147B2 (en) | UV protection preparation for cosmetic raw material and method for producing cosmetic containing the preparation | |
JP6927956B2 (en) | Aqueous cosmetic composition | |
JP7425782B2 (en) | Oil-in-water emulsion sunscreen cosmetics | |
JP6815093B2 (en) | Underwater oil type sunscreen cosmetics | |
EP3675804A2 (en) | Cosmetic compositions having antioxidant properties | |
JP6265371B2 (en) | Cosmetics | |
JP2018008907A (en) | Oil-in-water emulsion cosmetic | |
GB2562134A (en) | Sunscreen compositions | |
JP2007320906A (en) | Fine wrinkle improver | |
JP2015182994A (en) | Oil-in-water emulsion cosmetic | |
JP6741836B2 (en) | Oil-in-water emulsion cosmetic | |
JP7373264B2 (en) | sunscreen cosmetics | |
JPH09235217A (en) | Inorganic powder material and cosmetic using the same | |
JP6865522B2 (en) | Underwater oil type UV protection cosmetics | |
JP5855582B2 (en) | Photostable sunscreen composition | |
DE102010034389B4 (en) | Stabilized W / O emulsions | |
JP7152344B2 (en) | Oil-in-water cosmetics | |
JP2007137825A (en) | Cosmetics | |
JP6077216B2 (en) | Oily cosmetics | |
JP2018168134A (en) | Oil-in-water type cosmetic | |
KR20230132790A (en) | Oil-in-water emulsion cosmetics | |
FR2789997A1 (en) | Composition for use as cosmetic composition of antiperspirant comprises oil/in/water emulsion of polydimethyl siloxane, and inorganic agent | |
US11980678B2 (en) | Hybrid mineral and organic daily sunscreen thick cream moisturizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160602 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170726 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170808 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171005 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171212 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171213 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6265371 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |